{"id":"NCT01726049","sponsor":"University Medical Center Groningen","briefTitle":"Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH","officialTitle":"Effects of Sildenafil on Pulmonary Arterial Pressure in Patients With Heart Failure With Preserved Ejection Fraction ( HFpEF) and Pulmonary Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2014-09","completion":"2014-12","firstPosted":"2012-11-14","resultsPosted":"2016-03-21","lastUpdate":"2016-03-21"},"enrollment":52,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure, Diastolic","Pulmonary Hypertension"],"interventions":[{"type":"DRUG","name":"Sildenafil","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sildenafil","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Aim of the study is to investigate whether Sildenafil treatment results in a reduction of pulmonary artery pressure without decrease of cardiac output (CO) and in improvement of exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) with pulmonary hypertension ( PH).","primaryOutcome":{"measure":"Mean Pulmonary Artery Pressure Measured by Right Heart Catheterization","timeFrame":"baseline and 12 weeks","effectByArm":[{"arm":"Sildenafil","deltaMin":-2.4,"sd":null},{"arm":"Placebo","deltaMin":-4.7,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":1,"countries":["Netherlands"]},"refs":{"pmids":["27873388","26188003"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":26},"commonTop":["respiratory tract infection","myalgia","headache","visual impairment","nausea"]}}